NCT02701127View on ClinicalTrials.gov

Molecular Effects of Vitamin B3 (Niacinamide) in Acute Kidney Injury

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

February 28, 2017

Study Completion Date

July 31, 2017

Conditions
Acute Kidney Injury
Interventions
DRUG

Oral niacinamide, 1 gram daily

DRUG

Oral niacinamide, 3 gram daily

DRUG

Placebo

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
lead

Beth Israel Deaconess Medical Center

OTHER

NCT02701127 - Molecular Effects of Vitamin B3 (Niacinamide) in Acute Kidney Injury | Biotech Hunter | Biotech Hunter